Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd > Every goods news=down it goes

<< Previous

Bullboard Posts

Next >>

Comment by MrMonkon Dec 14, 2013 1:40pm

126 Views

Post# 22006426

RE:RE:Every goods news=down it goes

Board is definitely quiet. Busy time of year for many. Not much to say at this time. The key here is to remain solvent and wait out the storm. I think NOX can do this. Keep waiting is all we can do.

If you want to better understand their current cash position, e-mail Dale. You may not get hard numbers but then again you may.

-- MM

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects